Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal Impairment
Clinical trial NCT02182024 · COMPLETED
Trial details
- NCT number
- NCT02182024
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2006-03-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.